TCT 2025: STORM-PE Trial Demonstrates Safety and Efficacy of Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism
This news is covered by the Medical Dialogues Bureau present at the TCT Conference 2025, being held in San Francisco, USA.
The STORM-PE randomized controlled trial, presented at TCT 2025, demonstrated that computer-assisted vacuum thrombectomy combined with anticoagulation (CAVT) achieved a significantly greater improvement in right ventricular function compared with anticoagulation (AC) alone in patients with acute intermediate-high risk pulmonary embolism (PE).
The findings, presented by Dr. Robert Lookstein of Mount Sinai Health System, mark the first randomized trial in more than a decade to compare mechanical thrombectomy with standard anticoagulation for acute PE.
Author summary: TCT 2025 presents STORM-PE trial results.
More News
- What Mavericks’ Anthony Davis said after getting shut down by Thunder
- Pittsburgh Braces for Wintry Mix with Snow Accumulation
- Hudson’s Bay Downtown Vancouver Store for Sale
- Vikings' Jefferson: '25 one of most difficult seasons
- Hunt: Showdown Elaborates On Upcoming Player Profiles In Update 2.6
- Should you start or sit Justin Jefferson vs. Commanders?
- Celebrating America: Jefferson’s history, impact on East Texas
- ‘Happy Holidays’ Review
- Hudson Couteau de table en acier
- Tampa Bay Buccaneers quarterback Baker Mayfield elaborates on 'ebbs and flows' from late game heroics vs. Cardinals